Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 92.58 3.57% 3.19
ENTA closed up 3.57 percent on Friday, August 17, 2018, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Up
See historical ENTA trend table...

Date Alert Name Type % Chg
Aug 17 NR7 Range Contraction 0.00%
Aug 17 Multiple of Ten Bullish Other 0.00%
Aug 17 Wide Bands Range Expansion 0.00%
Aug 16 Calm After Storm Range Contraction 3.57%
Aug 16 Multiple of Ten Bearish Other 3.57%
Aug 16 Wide Bands Range Expansion 3.57%
Aug 15 Calm After Storm Range Contraction 5.22%
Aug 15 Doji - Bullish? Reversal 5.22%
Aug 15 Stochastic Reached Oversold Weakness 5.22%
Aug 15 Multiple of Ten Bearish Other 5.22%

Older signals for ENTA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.
Is ENTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 127.77
52 Week Low 37.92
Average Volume 311,396
200-Day Moving Average 84.315
50-Day Moving Average 110.6694
20-Day Moving Average 98.6105
10-Day Moving Average 91.895
Average True Range 5.9729
ADX 39.08
+DI 10.9949
-DI 32.1052
Chandelier Exit (Long, 3 ATRs ) 109.0513
Chandelier Exit (Short, 3 ATRs ) 99.1587
Upper Bollinger Band 117.2086
Lower Bollinger Band 80.0124
Percent B (%b) 0.34
BandWidth 37.720324
MACD Line -6.488
MACD Signal Line -5.9866
MACD Histogram -0.5013
Fundamentals Value
Market Cap 1.77 Billion
Num Shares 19.1 Million
EPS -1.08
Price-to-Earnings (P/E) Ratio -85.72
Price-to-Sales 23.12
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 98.48
Resistance 3 (R3) 97.88 95.33 97.49
Resistance 2 (R2) 95.33 93.83 95.62 97.16
Resistance 1 (R1) 93.95 92.90 94.64 94.55 96.84
Pivot Point 91.40 91.40 91.74 91.69 91.40
Support 1 (S1) 90.02 89.90 90.71 90.62 88.32
Support 2 (S2) 87.47 88.97 87.76 88.00
Support 3 (S3) 86.09 87.47 87.67
Support 4 (S4) 86.69